Hdfc Pharma And Healthcare Fund Overview
Category Pharma Fund
BMSMONEY Rank N/A
BMSMONEY Rating N/A
Gro. Opt. As On: 20-12-2024
NAV ₹16.45(R) -1.24% ₹16.7(D) -1.23%
Returns 1Y 3Y 5Y 7Y 10Y
LumpSum (R) 51.93% -% -% -% -%
LumpSum (D) 53.85% -% -% -% -%
SIP (R) -12.91% -% -% -% -%
SIP (D) -11.7% -% -% -% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
Top Pharma Fund
Fund Name Rank Rating
Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund -
Sbi Healthcare Opportunities Fund -
Dsp Healthcare Fund -
Tata India Pharma & Healthcare Fund -
Uti Healthcare Fund -

NAV Date: 20-12-2024

Scheme Name NAV Rupee Change Percent Change
HDFC Pharma and Healthcare Fund - IDCW Option 16.45
-0.2100
-1.2400%
HDFC Pharma and Healthcare Fund - Growth Option 16.45
-0.2100
-1.2400%
HDFC Pharma and Healthcare Fund - IDCW Option - Direct Plan 16.7
-0.2100
-1.2300%
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan 16.7
-0.2100
-1.2300%

Review Date: 20-12-2024

A review of the different performance parameters of the fund is as follows:
  1. Returns: It indicates the appreciation in the investment's value within the investment period, represented as a percentage or a specific amount of money. We conducted an analysis of the four return parameters of this fund to assess their performance. To assess performance, we have segmented the return parameters into three groups: the top 25%, parameters below the top 25% but still above average, and parameters below average. The results are provided below.
    1. Top 25%: Three return parameters of the HDFC Pharma And Healthcare Fund are in the top 25% in the category, as listed below:
      • 3M Return %
      • 6M Return %
      • 1Y Return %
    2. Above Average Below the Top 25%: The HDFC Pharma And Healthcare Fund has one return parameter in the category, which is above average but below the top 25%, as listed below:
      • 1M Return %
    3. Below Average: HDFC Pharma And Healthcare Fund has no return parameters that are below average in the category.
  2. Risk: The threat of not realizing projected profits or even facing financial loss due to different issues is known as risk. For HDFC Pharma And Healthcare Fund, we have analyzed zero risk parameters and divided them into three groups the lowest 25%, below average but above the lowest 25%, and above average, which are described below.
    1. Lowest 25%: HDFC Pharma And Healthcare Fund does not have any risk parameters in the lowest 25% of the category. It means high risk compared to other funds in the category.
    2. Below Average but Above the Lowest 25%: HDFC Pharma And Healthcare Fund does not have any risk parameters in the below average but above the lowest 25% of the category.
    3. Above Average: HDFC Pharma And Healthcare Fund does not have any risk parameters above average; which is a good sign.
  3. Risk Adjusted Performance Parameters: Risk-adjusted performance parameters in mutual funds are parameters that assess the return on investments based on the risks involved. These parameters provide a platform for investors to compare various investments, by considering both profits and the risks involved. For HDFC Pharma And Healthcare Fund, we have evaluated zero risk-adjusted performance parameters.
    1. Top 25% Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the top 25% of the category.
    2. Above Average Below Top 25% Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the above average but below top 25% of the category.
    3. Below Average Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the above average but below top 25% of the category.


Not able to see in mobile!!! save the chart by clicking on camera icon.

KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % 3.23
2.88
-0.97 | 4.52 6 | 13 Good
3M Return % 2.88
-0.40
-9.73 | 3.09 2 | 13 Very Good
6M Return % 25.79
19.11
3.40 | 26.27 2 | 13 Very Good
1Y Return % 51.93
42.49
33.84 | 51.93 1 | 12 Very Good
1Y SIP Return % -12.91
-21.85
-35.24 | -12.91 1 | 12 Very Good
Return data last Updated On : Dec. 20, 2024.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Nov. 29, 2024
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % 3.34 2.99 -0.84 | 4.64 6 | 13
3M Return % 3.21 -0.08 -9.36 | 3.54 2 | 13
6M Return % 26.57 19.88 4.26 | 27.36 2 | 13
1Y Return % 53.85 44.30 36.04 | 53.85 1 | 12
1Y SIP Return % -11.70 -20.75 -34.00 | -11.70 1 | 12
Return data last Updated On : Dec. 20, 2024.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Nov. 29, 2024
KPIs: Key Performance Indicators

Investment Period Regular Direct
Return % Current Value of ₹ 10000 Return % Current Value of ₹ 10000
1D -1.24 ₹ 9,876.00 -1.23 ₹ 9,877.00
1W 0.65 ₹ 10,065.00 0.68 ₹ 10,068.00
1M 3.23 ₹ 10,323.00 3.34 ₹ 10,334.00
3M 2.88 ₹ 10,288.00 3.21 ₹ 10,321.00
6M 25.79 ₹ 12,579.00 26.57 ₹ 12,657.00
1Y 51.93 ₹ 15,193.00 53.85 ₹ 15,385.00
3Y ₹ ₹
5Y ₹ ₹
7Y ₹ ₹
10Y ₹ ₹
15Y ₹ ₹

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.

Investment Period Invested Amount Regular Direct
XIRR % Current Value of Invested Amount XIRR % Current Value of Invested Amount
1Y ₹ 12000 -12.91 ₹ 11,144.03 -11.70 ₹ 11,225.23
3Y ₹ 36000 ₹ ₹
5Y ₹ 60000 ₹ ₹
7Y ₹ 84000 ₹ ₹
10Y ₹ 120000 ₹ ₹
15Y ₹ 180000 ₹ ₹


Date Hdfc Pharma And Healthcare Fund NAV Regular Growth Hdfc Pharma And Healthcare Fund NAV Direct Growth
20-12-2024 16.451 16.7
19-12-2024 16.657 16.908
18-12-2024 16.492 16.74
17-12-2024 16.335 16.58
16-12-2024 16.418 16.663
13-12-2024 16.344 16.587
12-12-2024 16.432 16.675
11-12-2024 16.52 16.765
10-12-2024 16.494 16.737
09-12-2024 16.522 16.765
06-12-2024 16.594 16.836
05-12-2024 16.595 16.837
04-12-2024 16.582 16.823
03-12-2024 16.597 16.837
02-12-2024 16.591 16.832
29-11-2024 16.466 16.703
28-11-2024 16.079 16.31
27-11-2024 16.164 16.395
26-11-2024 16.208 16.44
25-11-2024 16.311 16.544
22-11-2024 16.131 16.359
21-11-2024 15.937 16.161

Fund Launch Date: 04/Oct/2023
Fund Category: Pharma Fund
Investment Objective: To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
Fund Description: An open-ended equity scheme investing in Pharma and healthcare companies
Fund Benchmark: BSE Healthcare Index
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.